Anticonvulsant hypersensitivity syndrome. In vitro assessment of risk.
Open accessThe DOI matches its Crossref record; 15 of the 15 references it cites were found in a registry or an index.
Abstract
Arene oxide metabolites of aromatic anticonvulsants (phenytoin, phenobarbital, and carbamazepine) may be involved in the pathogenesis of hypersensitivity reactions. We investigated 53 patients with clinical sensitivity to anticonvulsants by exposing their lymphocytes in vitro to drug metabolites generated by a murine hepatic microsomal system. The diagnosis of a hypersensitivity reaction was corroborated by in vitro rechallenge for each drug (phenytoin, n = 34; phenobarbital, n = 22; carbamazepine, n = 25) when cytotoxicity (% dead cells) exceeded 3 SD above the mean result for controls. Cross-reactivity among the drugs was noted. 7 out of 10 patients who had received all three anticonvulsants had adverse reactions to each. 40 out of 50 patients tested to all three drugs in vitro were positive to each. Adverse reactions were indistinguishable among anti-convulsants. Skin rash (87%), fever (94%), hepatitis (51%), and hematologic abnormalities (51%) were common clinical features of each drug. 62% of reactions involved more than two organs. Cells from patients' parents exhibited in vitro toxicity that was intermediate between values for controls and patients. In vitro testing can help diagnose hypersensitivity to anticonvulsants. Cells from patients may also be used for prospective individualization of therapy to decrease risk of adverse reaction. Cross-reactivity among the major anticonvulsants is common and should be considered before deciding on alternative therapy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
SODIUM DIPHENYL HYDANTOINATE IN THE TREATMENT OF CONVULSIVE DISORDERS
MERRITT, H. H. (1938) · Journal of the American Medical Association · doi:10.1001/jama.1938.02790380010004 · Cited by 457
Differences in metabolism of sulfonamides predisposing to idiosyncratic toxicity
SHEAR, N. H., SPIELBERG, S. P., GRANT, D. M., TANG, B. K., & KALOW, W. (1986) · Annals of Internal Medicine · doi:10.7326/0003-4819-105-2-179 · Cited by 373
Self-citationSaltzstein, S. L., & Ackerman, L. V. (1959) · Cancer · doi:10.1002/1097-0142(195901/02)12:1<164::aid-cncr2820120122>3.0.co;2-y · Cited by 327
Predisposition to Phenytoin Hepatotoxicity Assessed in Vitro
Spielberg, S. P., Gordon, G. B., Blake, D. A., Goldstein, D. A., & Herlong, H. F. (1981) · New England Journal of Medicine · doi:10.1056/nejm198109243051302 · Cited by 234
Self-citationGENETIC PREDISPOSITION TO PHENYTOIN-INDUCED BIRTH DEFECTS
Strickler, S., Miller, M., Andermann, E., Dansky, L., Seni, M.-H., & Spielberg, S. (1985) · The Lancet · doi:10.1016/s0140-6736(85)90629-4 · Cited by 219
Self-citationDrug disposition and drug hypersensitivity
Kevin Park, B., Coleman, J. W., & Kitteringham, N. R. (1987) · Biochemical Pharmacology · doi:10.1016/0006-2952(87)90706-4 · Cited by 199
Lertratanangkoon, K., & Horning, M. G. (1982) · Drug Metabolism and Disposition · doi:10.1016/s0090-9556(25)07827-4 · Cited by 186
Anticonvulsant toxicity in vitro: possible role of arene oxides.
Spielberg, S. P., Gordon, G., Blake, D. A., Mellits, E. D., & Bross, D. (1981) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)32544-9 · Cited by 139
Self-citationHaruda, F. D. (1979) · Neurology · doi:10.1212/wnl.29.11.1480 · Cited by 121
Anticonvulsant-induced aplastic anemia: increased susceptibility to toxic drug metabolites in vitro
Gerson, W., Fine, D., Sp, S., & Sensenbrenner, L. (1983) · Blood · doi:10.1182/blood.v61.5.889.889 · Cited by 103
Cited by
Severe Adverse Cutaneous Reactions to Drugs
Roujeau, J. C., & Stern, R. S. (1994) · New England Journal of Medicine · doi:10.1056/nejm199411103311906 · Cited by 1,571
The DRESS Syndrome: A Literature Review
Cacoub, P., Musette, P., Descamps, V., Meyer, O., Speirs, C., Finzi, L., & Roujeau, J. C. (2011) · The American Journal of Medicine · doi:10.1016/j.amjmed.2011.01.017 · Cited by 1,012
Kardaun, S. H., Sekula, P., Valeyrie-Allanore, L., Liss, Y., Chu, C. Y., Creamer, D., Sidoroff, A., Naldi, L., Mockenhaupt, M., Roujeau, J. C., et al. (2013) · British Journal of Dermatology · doi:10.1111/bjd.12501 · Cited by 1,010
Bocquet, H., Bagot, M., & Roujeau, J. C. (1996) · Seminars in Cutaneous Medicine and Surgery · doi:10.1016/s1085-5629(96)80038-1 · Cited by 964
Evans, D. C., Watt, A. P., Nicoll-Griffith, D. A., & Baillie, T. A. (2004) · Chemical Research in Toxicology · doi:10.1021/tx034170b · Cited by 706
Stepan, A. F., Walker, D. P., Bauman, J., Price, D. A., Baillie, T. A., Kalgutkar, A. S., & Aleo, M. D. (2011) · Chemical Research in Toxicology · doi:10.1021/tx200168d · Cited by 698
Husain, Z., Reddy, B. Y., & Schwartz, R. A. (2013) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2013.01.033 · Cited by 489
Shiohara, T., Inaoka, M., & Kano, Y. (2006) · Allergology International · doi:10.2332/allergolint.55.1 · Cited by 485
Abboud, G., & Kaplowitz, N. (2007) · Drug Safety · doi:10.2165/00002018-200730040-00001 · Cited by 479
Anticonvulsant Hypersensitivity Syndrome
Vittorio, C. C. (1995) · Archives of Internal Medicine · doi:10.1001/archinte.155.21.2285 · Cited by 436
Kaplowitz, N. (2004) · Clinical Infectious Diseases · doi:10.1086/381446 · Cited by 402
Idiosyncratic Adverse Reactions to Antiepileptic Drugs
Zaccara, G., Franciotta, D., & Perucca, E. (2007) · Epilepsia · doi:10.1111/j.1528-1167.2007.01041.x · Cited by 364
Drug Reaction With Eosinophilia and Systemic Symptoms: A Retrospective Study of 60 Cases
Chen, Y.-C., Chiu, H.-C., & Chu, C.-Y. (2010) · Archives of Dermatology · doi:10.1001/archdermatol.2010.198 · Cited by 350
Peyrière, H., Dereure, O., Breton, H., Demoly, P., Cociglio, M., Blayac, J.-P., Hillaire-Buys, D., & the Network of the French Pharmacovigilance Centers (2006) · British Journal of Dermatology · doi:10.1111/j.1365-2133.2006.07284.x · Cited by 348
Risk Factors for Idiosyncratic Drug-Induced Liver Injury
Chalasani, N., & Björnsson, E. (2010) · Gastroenterology · doi:10.1053/j.gastro.2010.04.001 · Cited by 347
Tohyama, M., Hashimoto, K., Yasukawa, M., Kimura, H., Horikawa, T., Nakajima, K., Urano, Y., Matsumoto, K., Iijima, M., & Shear, N. H. (2007) · British Journal of Dermatology · doi:10.1111/j.1365-2133.2007.08167.x · Cited by 341
Self-citationRash in Multicenter Trials of Lamotrigine in Mood Disorders: Clinical Relevance and Management
Calabrese, J. R., Sullivan, J. R., Bowden, C. L., Suppes, T., Goldberg, J. F., Sachs, G. S., Shelton, M. D., Goodwin, F. K., Frye, M. A., & Kusumakar, V. (2002) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v63n1110 · Cited by 334
Idiosyncratic drug reactions: the reactive metabolite syndromes
Knowles, S. R., Uetrecht, J., & Shear, N. H. (2000) · The Lancet · doi:10.1016/s0140-6736(00)03137-8 · Cited by 331
Self-citationGenetic susceptibility to adverse drug reactions
Pirmohamed, M., & Park, B. K. (2001) · Trends in Pharmacological Sciences · doi:10.1016/s0165-6147(00)01717-x · Cited by 328
Role of Metabolism in Drug-Induced Idiosyncratic Hepatotoxicity
Walgren, J. L., Mitchell, M. D., & Thompson, D. C. (2005) · Critical Reviews in Toxicology · doi:10.1080/10408440590935620 · Cited by 322
Adverse drug reactions induced by valproic acid
Nanau, R. M., & Neuman, M. G. (2013) · Clinical Biochemistry · doi:10.1016/j.clinbiochem.2013.06.012 · Cited by 321
Shiohara, T., & Mizukawa, Y. (2019) · Allergology International · doi:10.1016/j.alit.2019.03.006 · Cited by 318
Stevens-Johnson syndrome and toxic epidermal necrolysis: a review of the literature
Letko, E., Papaliodis, D. N., Papaliodis, G. N., Daoud, Y. J., Ahmed, A. R., & Foster, C. S. (2005) · Annals of Allergy, Asthma & Immunology · doi:10.1016/s1081-1206(10)61112-x · Cited by 316
Idiosyncratic Adverse Drug Reactions: Current Concepts
Uetrecht, J., & Naisbitt, D. J. (2013) · Pharmacological Reviews · doi:10.1124/pr.113.007450 · Cited by 310
Epoxide hydrolases: biochemistry and molecular biology
Fretland, A. J., & Omiecinski, C. J. (2000) · Chemico-Biological Interactions · doi:10.1016/s0009-2797(00)00197-6 · Cited by 307
Clinical Biochemistry of Hepatotoxicity
P Sharma, O. (2014) · Journal of Clinical Toxicology · doi:10.4172/2161-0495.s4-001 · Cited by 305
Idiosyncratic Drug Reactions: Current Understanding
Uetrecht, J. (2007) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.47.120505.105150 · Cited by 304
Uetrecht, J. P. (1999) · Chemical Research in Toxicology · doi:10.1021/tx980249i · Cited by 304
Anticonvulsant Hypersensitivity Syndrome: Incidence, Prevention and Management
Knowles, S. R., Shapiro, L. E., & Shear, N. H. (1999) · Drug Safety · doi:10.2165/00002018-199921060-00005 · Cited by 303
Self-citationCho, Y.-T., Yang, C.-W., & Chu, C.-Y. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18061243 · Cited by 286
The clinical impact of pharmacogenetics on the treatment of epilepsy
Löscher, W., Klotz, U., Zimprich, F., & Schmidt, D. (2009) · Epilepsia · doi:10.1111/j.1528-1167.2008.01716.x · Cited by 281
Central role of mitochondria in drug-induced liver injury
Pessayre, D., Fromenty, B., Berson, A., Robin, M.-A., Lettéron, P., Moreau, R., & Mansouri, A. (2012) · Drug Metabolism Reviews · doi:10.3109/03602532.2011.604086 · Cited by 277
Role of Drug Disposition in Drug Hypersensitivity: A Chemical, Molecular, and Clinical Perspective
Park, B. K., Pirmohamed, M., & Kitteringham, N. R. (1998) · Chemical Research in Toxicology · doi:10.1021/tx980058f · Cited by 267
Svensson, C. K., Cowen, E. W., & Gaspari, A. A. (2001) · Pharmacological Reviews · doi:10.1016/s0031-6997(24)01501-1 · Cited by 267
Tohyama, M., Yahata, Y., Yasukawa, M., Inagi, R., Urano, Y., Yamanishi, K., & Hashimoto, K. (1998) · Archives of Dermatology · doi:10.1001/archderm.134.9.1113 · Cited by 266
Drug-Induced Liver Disorders: Implications for Drug Development and Regulation
Kaplowitz, N. (2001) · Drug Safety · doi:10.2165/00002018-200124070-00001 · Cited by 260
Children versus adults: pharmacokinetic and adverse-effect differences
Anderson, G. D. (2002) · Epilepsia · doi:10.1046/j.1528-1157.43.s.3.5.x · Cited by 187
Zimmerman, H. J. (2000) · Clinics in Liver Disease · doi:10.1016/s1089-3261(05)70097-0 · Cited by 186
Immune-mediated drug-induced liver disease
Liu, Z.-X., & Kaplowitz, N. (2002) · Clinics in Liver Disease · doi:10.1016/s1089-3261(02)00025-9 · Cited by 170
Drug-induced autoimmune liver disease: A diagnostic dilemma of an increasingly reported disease
Castiella, A. (2014) · World Journal of Hepatology · doi:10.4254/wjh.v6.i4.160 · Cited by 131
Sachs, B., Erdmann, S., Malte Baron, J., Neis, M., Al Masaoudi, T., & Merk, H. F. (2002) · Clinical & Experimental Allergy · doi:10.1046/j.1365-2222.2002.01382.x · Cited by 74
Metadata
- Authors
- Shear, N. H., & Spielberg, S. P.
- Venue
- Journal of Clinical Investigation
- Published
- 1988-12-01
- Volume
- 82
- Issue
- 6
- Pages
- 1826-1832
- ISSN
- 0021-9738 (ISSN-L)
- OpenAlex
- W2079198255
- Cited by
- 687
- References
- 15
- FWCI
- 10.28
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.